Skip to main content
2025 CRT Conference Main banner
Back

Kashish Goel, MD

Director, Transcatheter Heart Valve Interventions
Vanderbilt University Medical Center
Nashville, Tennessee, United States

Dr. Kashish Goel is the Director of Transcatheter Heart Valve Interventions at Vanderbilt University Medical Center. He is a high-volume operator with expertise in transcatheter interventions for mitral, tricuspid and aortic valve disease. He is the site PI for multiple early feasibility studies of mitral and tricuspid valve replacement devices and an investigator in several ongoing international clinical trials. Dr. Goel also serves on the steering committee for upcoming pivotal clinical trials, sits on scientific advisory boards and is a clinical proctor for transcatheter procedures. Dr. Goel is a prolific clinical researcher and has published more than 100 publications with first-author publications in JACC, Circulation, EHJ, and JAMA Cardiology. He is a member of the SCAI Structural Council and the prestigious SCAI Emerging Leaders Mentorship (ELM) program.

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing); Abbott Vascular Devices: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Laplace: Grant/Research Support (Ongoing); Medtronic Inc: Grant/Research Support (Ongoing); Teleflex Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Presentation(s):